Back to results
US 8,710,049 B2Granted
Diaminocyclohexane compounds and uses thereof
AssigneeBristol-Myers Squibb Company
InventorsWilliam R. Ewing, Yeheng Zhu, Chongqing Sun, Yanting Huang, Maheswaran Sivasamban Karatholuvhu
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are agonists, partial agonists and modulators of the NPY Y4 receptor and may be used for the treatment and prophylaxis of various diseases and conditions.
Claims10
A compound of formula Ia
- wherein
- X is CH2, O, or NH;
- B is absent or is —(CH2)m—;
- R is H or (C1-C6)alkyl;
- R1 is (C6)aryl or 5- to 8-membered cycloalkyl or 5- to 8-membered heteroaryl, said heteroaryl containing 1-4 heteroatoms selected from N, O, and S, wherein the cycloalkyl, aryl and heteroaryl may be optionally substituted with one or more R3;
- R2 is (C6)aryl or 5- to 8-membered heteroaryl, said heteroaryl containing 1-4 heteroatoms selected from N, O, and S, wherein both the aryl and heteroaryl may be optionally substituted with one or more R4, wherein R2 is connected to ring A through the nitrogen atom;
- R3 is independently one or more halogen, —OH, —CN, —NO2, —COOH, —CO2(C1-C6)alkyl, —CF3, —OCHF2, —OCF3, —(C1-C6)-alkyl, —(C1-C6)-alkyloxy, —CON R9R10, —O(C═O)NR9R10, —NR9R10, —(C1-C6)-alkylCOOH, —(C1-C6)-alkyl-CO2(C1-C6)-alkyl, —(C1-C6)-alkylOH, —(C1-C6)-alkylCON R9R10, —(C6-10)aryl, a 5- to 8-membered heteroaryl, which contains 1-4 heteroatoms selected from N, O, and S;
- and a 5- to 10-membered heterocyclyl, which contains 1-4 heteroatoms selected from N, O, and S;
- wherein any alkyl, aryl, heteroaryl, and heterocyclyl may be optionally substituted with one or more substituents selected from the group consisting of:
- halo, —OH, cyano, nitro, —CF3, —OCF3, —OCF2, (C1-C6)-alkyl, (C2-C6)-alkynyl, (C1-C6)-alkyloxy, —COOH, —CO2(C1-C6)-alkyl, —CONR9R10, —NR9R10, —O(C—O)—(C1-C6)-alkyl, —O(C—O)NR9R10;
- —(C1-C6)-alkylCOOH, —(C1-C6)-alkylOH, —(C1-C6)-alkylCONR9R10, —(C1-C6)-alkyl-CO2(C1-C6)-alkyl, (C6-10)aryl, a 5- to 8-membered heteroaryl, which contains 1-4 heteroatoms selected from N, O, and S, a 5- to 10-membered heterocyclyl, which contains 1-4 heteroatoms selected from N, O, and S;
- or R3 and another R3 can optionally be taken together with the carbon atom that they are attached to form a —(C4-C8)cycloalkyl, —(C6)aryl, a 5- to 8-membered heterocyclyl, which contains 1-4 heteroatoms selected from N, O, and S, or a 5- to 8-membered heteroaryl ring, which contains 1-4 heteroatoms selected from N, O, and S, that may be optionally substituted with one or more substituents selected from the group consisting of:
- halo, —OH, cyano, nitro, —CF3, —OCF3, —OCF2, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkyloxy, —COOH, —CO2(C1-C6)-alkyl, —CONR9R10, —NR9R10, —O(C═O)—(C1-C6)-alkyl, —O(C═O)NR9R10;
- —(C1-C6)-alkylCOOH, —(C1-C6)-alkylOH, —(C1-C6)-alkylCONR9R10, —(C1-C6)-alkyl-CO2(C1-C6)-alkyl, (C6-10)aryl, a 5- to 8-membered heteroaryl, which contains 1-4 heteroatoms selected from N, O, and S, a 5- to 10-membered heterocyclo, which contains 1-4 heteroatoms selected from N, O, and S;
- halo(C1-C6)alkyl, and halo(C1-C6)alkyloxy;
- R4 is halogen, —OH, CF3, —OCF2, —OCF3, —CN, —NO2, —COOH, (C1-C6)-alkyl, (C1-C6)-alkyloxy, —CO(C1-C6)-alkyl, —CO2(C1-C6)-alkyl, —CONR9R10, —NR9R10, or a 5- to 10-membered heteroaryl containing 1-4 heteroatoms selected from N, O, and S, optionally substituted with one or more R5;
- R5 is halogen, —OH, —CF3, —OCF2, —OCF3, —CN, —NO2, —(C1-C6)alkyl, or —(C1-C6)alkyloxy;
- R6 is halogen, —OH, (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
- R9 and R10, at each occurrence, are independently hydrogen or (C1-C8)-alkyl, wherein the alkyl may be optionally substituted with one or more R11's;
- or R9 and R10 are taken together with the nitrogen to which both are attached to form a 3- to 8-membered ring, which may optionally contain 1-4 heteroatoms selected from N, O, and S and be optionally substituted with one or more R11's;
- R11 is halo, —OH, cyano, (C1-C6)-alkyl;
- m is 1, 2, to 3;
- n is 1, 2 or 3;
- or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof.
21 more elements
A compound of formula Ib
- wherein
- X is CH2, O, or NH;
- B is absent or is (CH2)m—;
- R is H or (C1-C6)alkyl;
- R1 is (C6)aryl or 5- to 8-membered cycloalkyl or 5- to 8-membered heteroaryl, said heteroaryl containing 1-4 heteroatoms selected from N, O, and S, wherein the cycloalkyl, aryl and heteroaryl may be optionally substituted with one or more R3;
- R2 is (C6)aryl or 5- to 8-membered heteroaryl, said heteroaryl containing 1-4 heteroatoms selected from N, O, and S, wherein both the aryl and heteroaryl may be optionally substituted with one or more R4, wherein R2 is connected to ring A through the nitrogen atom;
- R3 is independently one or more halogen, —OH, —CN, —NO2, —COOH, —CO2(C1-C6)alkyl, —CF3, —OCHF2, —OCF3, —(C1-C6)-alkyl, —(C1-C6)-alkyloxy, —CONR9R10, —O(C═O)NR9R10, —NR9R10, —(C1-C6)-alkylCOOH, —(C1-C6)-alkyl-CO2(C1-C6)-alkyl, —(C1-C6)-alkylOH, —(C1-C6)-alkylCONR9R10, —(C6-10)aryl, a 5- to 8-membered heteroaryl, which contains 1-4 heteroatoms selected from N, O, and S;
- and a 5- to 10-membered heterocyclyl, which contains 1-4 heteroatoms selected from N, O, and S;
- wherein any alkyl, aryl, heteroaryl, and heterocyclyl may be optionally substituted with one or more substituents selected from the group consisting of:
- halo, —OH, cyano, nitro, —CF3, —OCF3, —OCF2, (C1-C6)-alkyl, (C2-C6)-alkynyl, (C1-C6)-alkyloxy, —COOH, —CO2(C1-C6)-alkyl, —CONR9R10, —NR9R10, —O(C═O)—(C1-C6)-alkyl, —O(C═O)NR9R10;
- —(C1-C6)-alkylCOOH, —(C1-C6)-alkylOH, —(C1-C6)-alkylCONR9R10, —(C1-C6)-alkyl-CO2(C1-C6)-alkyl, (C6-C10)aryl, a 5- to 8-membered heteroaryl, which contains 1-4 heteroatoms selected from N, O, and S, a 5- to 10-membered heterocyclyl, which contains 1-4 heteroatoms selected from N, O, and S;
- or R3 and another R3 can optionally be taken together with the carbon atom that they are attached to form a —(C4-C8)cycloalkyl, —(C6)aryl, a 5- to 8-membered heterocyclyl, which contains 1-4 heteroatoms selected from N, O, and S, or a 5- to 8-membered heteroaryl ring, which contains 1-4 heteroatoms selected from N, O, and S, that may be optionally substituted with one or more substituents selected from the group consisting of:
- halo, —OH, cyano, nitro, —CF3, —OCF3, —OCF2, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkyloxy, —COOH, —CO2(C1-C6)-alkyl, —CONR9R10, —NR9R10, —O(C═O)—(C1-C6)-alkyl, —O(C═O)NR9R10;
- —(C1-C6)-alkylCOOH, —(C1-C6)-alkylOH, —(C1-C6)-alkylCONR9R10, —(C1-C6)-alkyl-CO2(C1-C6)-alkyl, (C6-10)aryl, a 5- to 8-membered heteroaryl, which contains 1-4 heteroatoms selected from N, O, and S, a 5- to 10-membered heterocyclo, which contains 1-4 heteroatoms selected from N, O, and S;
- halo(C1-C6)alkyl, and halo(C1-C6)alkyloxy;
- R4 is halogen, —OH, CF3, —OCF2, —CN, —NO2, —COOH, (C1-C6)-alkyl, alkyloxy, —CO(C1-C6)-alkyl, —CO2(C1-C6)-alkyl, —CONR9R10, —NR9R10, or a 5- to 10-membered heteroaryl containing 1-4 heteroatoms selected from N, O, and S, optionally substituted with one or more R5;
- R5 is halogen, —OH, —CF3, —OCF2, —OCF3, —CN, —NO2, —(C1-C6)alkyl, or —(C1-C6)alkyloxy;
- R6 is halogen, —OH, (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
- R9 and R10, at each occurrence, are independently hydrogen or (C1-C8)-alkyl, wherein the alkyl may be optionally substituted with one or more R11's;
- or R9 and R10 are taken together with the nitrogen to which both are attached to form a 3- to 8-membered ring, which may optionally contain 1-4 heteroatoms selected from N, O, and S and be optionally substituted with one or more R11's;
- R11 is halo, —OH, cyano, (C1-C6)-alkyl;
- m is 1, 2, to 3;
- n is 1, 2 or 3;
- or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof.
21 more elements
A compound of formula Ic
- wherein
- X is CH2, O, or NH;
- B is absent or is —(CH2)m—;
- R is H or (C1-C6)alkyl;
- R1 is (C6)aryl or 5- to 8-membered cycloalkyl or 5- to 8-membered heteroaryl, said heteroaryl containing 1-4 heteroatoms selected from N, O, and S, wherein the cycloalkyl, aryl and heteroaryl may be optionally substituted with one or more R3;
- R2 is (C6)aryl or 5- to 8-membered heteroaryl, said heteroaryl containing 1-4 heteroatoms selected from N, O, and S, wherein both the aryl and heteroaryl may be optionally substituted with one or more R4, wherein R2 is connected to ring A through the nitrogen atom;
- R3 is independently one or more halogen, —OH, —CN, —NO2, —COOH, —CO2(C1-C6)alkyl, —CF3, —OCHF2, —OCF3, —(C1-C6)-alkyl, —(C1-C6)-alkyloxy, —CON R9R10, —O(C═O)NR9R10, —NR9R10, —(C1-C6)-alkylCOOH, —(C1-C6)-alkyl-CO2(C1-C6)-alkyl, —(C1-C6)-alkylOH, —(C1-C6)-alkylCON R9R10, —(C6-10)aryl, a 5- to 8-membered heteroaryl, which contains 1-4 heteroatoms selected from N, O, and S;
- and a 5- to 10-membered heterocyclyl, which contains 1-4 heteroatoms selected from N, O, and S;
- wherein any alkyl, aryl, heteroaryl, and heterocyclyl may be optionally substituted with one or more substituents selected from the group consisting of:
- halo, —OH, cyano, nitro, —CF3, —OCF3, —OCF2, (C1-C6)-alkyl, (C2-C6)-alkynyl, (C1-C6)-alkyloxy, —COOH, —CO2(C1-C6)-alkyl, —CONR9R10, —NR9R10, —O(C═O)—(C1-C6)-alkyl, —O(C═O)NR9R10;
- —(C1-C6)-alkylCOOH, —(C1-C6)-alkylOH, —(C1-C6)-alkylCONR9R10, —(C1-C6)-alkyl-CO2(C1-C6)-alkyl, (C6-10)aryl, a 5- to 8-membered heteroaryl, which contains 1-4 heteroatoms selected from N, O, and S, a 5- to 10-membered heterocyclyl, which contains 1-4 heteroatoms selected from N, O, and S;
- or R3 and another R3 can optionally be taken together with the carbon atom that they are attached to form a —(C4-C8)cycloalkyl, —(C6)aryl, a 5- to 8-membered heterocyclyl, which contains 1-4 heteroatoms selected from N, O, and S, or a 5- to 8-membered heteroaryl ring, which contains 1-4 heteroatoms selected from N, O, and S, that may be optionally substituted with one or more substituents selected from the group consisting of:
- halo, —OH, cyano, nitro, —CF3, —OCF3, —OCF2, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkyloxy, —COOH, —CO2(C1-C6)-alkyl, —CONR9R10, —NR9R10, —O(C═O)—(C1-C6)-alkyl, —O(C═O)NR9R10;
- —(C1-C6)-alkylCOOH, —(C1-C6)-alkylOH, —(C1-C6)-alkylCONR9R10, —(C1-C6)-alkyl-CO2(C1-C6)-alkyl, (C6-10)aryl, a 5- to 8-membered heteroaryl, which contains 1-4 heteroatoms selected from N, O, and S, a 5- to 10-membered heterocyclo, which contains 1-4 heteroatoms selected from N, O, and S;
- halo(C1-C6)alkyl, and halo(C1-C6)alkyloxy;
- R4 is halogen, —OH, CF3, —OCF2, —OCF3, —CN, —NO2, —COOH, (C1-C6)-alkyl, (C1-C6)-alkyloxy, —CO(C1-C6)-alkyl, —CO2(C1-C6)-alkyl, —CONR9R10, —NR9R10, or a 5- to 10-membered heteroaryl containing 1-4 heteroatoms selected from N, O, and S, optionally substituted with one or more R5;
- R5 is halogen, —OH, —CF3, —OCF2, —OCF3, —CN, —NO2, —(C1-C6)alkyl, or —(C1-C6)alkyloxy;
- R6 is halogen, —OH, (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
- R9 and R10, at each occurrence, are independently hydrogen or (C1-C8)-alkyl, wherein the alkyl may be optionally substituted with one or more R11's;
- or R9 and R10 are taken together with the nitrogen to which both are attached to form a 3- to 8-membered ring, which may optionally contain 1-4 heteroatoms selected from N, O, and S and be optionally substituted with one or more R11's;
- R11 is halo, —OH, cyano, (C1-C6)-alkyl;
- m is 1, 2, to 3;
- n is 1, 2 or 3;
- or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof.
21 more elements
Dependencies are inferred from the claim text.